Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.
Iurlo A, Elli EM, Palandri F, Cattaneo D, Bossi A, Cortinovis I, Bucelli C, Orofino N, Brioschi F, Auteri G, Bianchi P, Fabris S, Isimbaldi G, Sabattini E, Baldini L, Gianelli U. Iurlo A, et al. Among authors: baldini l. Hematol Oncol. 2019 Oct;37(4):424-433. doi: 10.1002/hon.2658. Epub 2019 Aug 22. Hematol Oncol. 2019. PMID: 31359447
Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study.
Bucelli C, Fattizzo B, Cattaneo D, Giannotta JA, Barbullushi K, Pasquale R, Barozzi E, Barbanti MC, Pettine L, Rossi FG, Reda G, Cassin R, Barcellini W, Baldini L, Iurlo A. Bucelli C, et al. Among authors: baldini l. Front Oncol. 2021 Oct 18;11:701604. doi: 10.3389/fonc.2021.701604. eCollection 2021. Front Oncol. 2021. PMID: 34733777 Free PMC article.
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter series.
Iurlo A, Palandri F, Maria Elli E, Cattaneo D, Bucelli C, Sciumè M, Vincelli D, Brioschi F, Auteri G, Croci GA, Guerneri S, Isimbaldi G, Sabattini E, Cortinovis I, Bossi A, Rosti V, Martino B, Baldini L, Gianelli U. Iurlo A, et al. Among authors: baldini l. Hematol Oncol. 2021 Feb;39(1):123-128. doi: 10.1002/hon.2808. Epub 2020 Oct 4. Hematol Oncol. 2021. PMID: 32979286
Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study.
Cattaneo D, Croci GA, Bucelli C, Tabano S, Cannone MG, Gaudioso G, Barbanti MC, Barbullushi K, Bianchi P, Fermo E, Fabris S, Baldini L, Gianelli U, Iurlo A. Cattaneo D, et al. Among authors: baldini l. Front Oncol. 2021 Mar 12;11:637116. doi: 10.3389/fonc.2021.637116. eCollection 2021. Front Oncol. 2021. PMID: 33791220 Free PMC article.
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy).
Fattizzo B, Giannotta JA, Barcellini W, Barbanti MC, Bucelli C, Cassin R, Cattaneo D, Cavallaro F, Ferla V, Fracchiolla NS, Freyrie A, Galassi G, Goldaniga MC, Grifoni FI, Iurlo A, Mangiameli G, Mattiello V, Meli M, Neri A, Noto A, Onida F, Ottani L, Pasquale R, Pettine L, Pompa A, Reda G, Rossi FG, Saporiti GN, Sciumè M, Tagliaferri E, Baldini L. Fattizzo B, et al. Among authors: baldini l. Blood Adv. 2020 Jul 14;4(13):2996-2999. doi: 10.1182/bloodadvances.2020002120. Blood Adv. 2020. PMID: 32609844 Free PMC article. No abstract available.
528 results